New Study Reveals Link Between Antidepressants and Birth Defects
Nadrich & Cohen LLP has been investigating the link between selective serotonin reuptake inhibitors (SSRIs) and birth defects for years, and we have helped numerous women to win recoveries from the pharmaceutical companies as a result of SSRI birth defects relating to drugs like Zoloft. Now, a new study further solidifies the link between these antidepressants and birth defects.
According to the new study, pregnant women who stake SSRIs may have a greater risk of pregnancy complications, such as pre-term birth, birth defects, and even miscarriage. While some mental health experts have criticized the review for overstating the risks of SSRIs and downplaying the benefits of depression treatment, the issue of birth defects is no trivial matter and deserves serious attention.
Dr. Adam Urato, chairman of obstetrics and gynecology at MetroWest Medical Center in Massachusetts, told the Huffington Post that “There needs to be greater awareness of scientific evidence regarding the use of these drugs.” Urato argues that the study was unfairly characterized as an attack on women who take the popular birth control drugs, but that’s not really the issue at hand.
The fact is, most women who take SSRIs are unaware of the birth control risks, and therein lies the problem. It’s not an “attack” on women to point out the risks; in fact, it’s a cautionary note to women. Drug manufacturers are notorious for downplaying the risks of various types of pharmaceuticals, for fear that any negative press may hurt their bottom line. But people have the right to know what their drugs may be doing to them.
At Nadrich & Cohen, we agree that women should not be attacked or criticized for treating their illnesses, whatever the symptoms may be. The problem is a lack of awareness and a lack of action on the part of the FDA. The women filing lawsuits against the SSRI manufacturers are the victims, not the culprits, and that’s why we fight aggressively to win recoveries for these women.
Even Dr. Urato admits that the potential problems associated with SSRI use during pregnancy are “substantial..” Problems include increased risk of miscarriage, preterm birth, birth defects, pulmonary hypertension of the infant, and even long-term neurobehavioral issues.
According to Dr. Urato, “The data is concerning, and it’s growing as we do more and more studies. We would encourage transparency here. We would encourage readers to look at these studies.”
If you have experienced any of the aforementioned birth defects or birth-related issues after taking SSRIs, you may be entitled to monetary compensation. Contact the aggressive attorneys at Nadrich & Cohen LLP at 1-800-718-4658 to receive a free, confidential consultation. Don’t wait another moment.